Immunotherapy: A New Challenge in Treating Cancer
Deadline for manuscript submissions: closed (15 December 2023) | Viewed by 18964
Interests: cancer therapy; HCC; immunotherapy; notch signaling; flow cytometry
Special Issues, Collections and Topics in MDPI journals
Immunotherapy, and specifically checkpoint inhibitors, have a remarkably impressive, positive impact on clinical outcomes in an ever-increasing number of clinical settings. Immunotherapy advances can be applied to several immune-mediated pathologies, and the success achieved with some types of immunotherapies in recent years is revealing new ways to explore and manipulate the immune system to our benefit.
This Special Issue welcomes original research papers or comprehensive reviews addressing every aspect of this topic, including function and regulation in biology and medicine. Our aim is for interdisciplinary applications of the knowledge to stimulate future research.
Dr. Catia Giovannini
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- checkpoint inhibitors
- human diseases
- combined treatments